Stockreport

GH Research Reports Third Quarter 2025 Financial Results and Provides Business Updates [Yahoo! Finance]

GH Research PLC - Ordinary Shares  (GHRS) 
PDF Long-term clinical data on safety and efficacy from Open-Label Extension presented at ECNP in October 2025 Cash, cash equivalents and marketable securities of $293.9 [Read more]